期刊
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
卷 11, 期 9, 页码 844-853出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/187152011797655131
关键词
Sphingolipid; autophagy; ceramide; sphingosine-1-phosphate; cancer; hematological malignancies
资金
- INSERM
- Universite Paul Sabatier and Agencia de Gestio d'Ajuts Universitaris i Recerca
- Generalitat de Catalunya [2007-BP-A00129, 2009-BP-B00111]
Autophagy is an evolutionary conserved process by which cells recycle intracellular materials to maintain homeostasis in different cellular contexts. Under basal conditions it prevents accumulation of damaged proteins and organelles; during starvation, autophagy provides cells with sufficient nutrients to survive. Sphingolipids are a family of bioactive molecules modulating vital cellular functions such as apoptosis, cell cycle arrest or proliferation. Besides these functions, some sphingolipids like ceramide, sphingosine-1-phosphate or gangliosides have been described to promote autophagy in several cancer cell lines. Current evidence supports the notion that induction of autophagic cell death can halt tumorigenesis. Of interest, some chemotherapeutic agents used for the treatment of hematological malignancies trigger the production of endogenous sphingolipids with pro-autophagic effects. In this review we describe the regulation and functions of the sphingolipid-induced autophagy and the tight relationship with the cancer cell response to current chemotherapeutic regimens.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据